Article - The Marshall Protocol for Lyme Disease and other chronic inflammatory conditions

Type: Article
Author: Joyce Waterhouse PhD
Publication: Townsend letter
Citation: Waterhouse, J. The Marshall ProtocolA curative medical treatment for chronic inflammatory disease. Based on the Marshall Pathogenesis. for Lyme Disease and other chronic inflammatory conditions. Townsend Letter (2007).
Related content: full text of Part One; full text of Part Two


A new approach called the Marshall Protocol (MP), is now achieving success in treating chronic Lyme disease. This protocol was originally developed for sarcoidosis by Trevor Marshall PhD, of the Autoimmunity Research FoundationNon-profit foundation dedicated to exploring a pathogenesis and therapy for chronic disease.. The MP's main targets are the treatment-resistanct cell wall deficient (CWD, L-formDifficult-to-culture bacteria that lack a cell wall and are not detectable by traditional culturing processes. Sometimes referred to as cell wall deficient bacteria. or cyst) forms of Borrelia burgdorferi (Bb) and a variety of other bacterial species - though it also kills spirochetal/classical bacterial forms.

home/publications/waterhouse_mp_for_lyme_2007.txt · Last modified: 07.04.2022 by
© 2015, Autoimmunity Research Foundation. All Rights Reserved.